World
Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated...
May 04, 2023 | News
This new Agilent 8697 -XL Tray also includes the latest instrument intelligence features for increased uptime and operator ease-of-use compared to it...
May 04, 2023 | News
U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy i...
May 04, 2023 | News
Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...
May 09, 2023 | News
Holistic IoT device and lab management solution With research and development being a time-consuming industry, there is a constant need for time-saving di...
May 02, 2023 | News
MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...
May 02, 2023 | News
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval ...
May 02, 2023 | News
Pall Life Sciences and Cytiva have united under the Cytiva name — forming an even stronger global provider of technologies and services that advanc...
May 02, 2023 | News
The CDC has recommended the bivalent mRNA COVID-19 vaccines since September 2022, yet only 42.4 percent of older adults have received the updated vacc...
May 02, 2023 | News
This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...
May 01, 2023 | Regulatory
Over 250 events expected to reach more than 45,000 future scientists on two continents Hands-on experiments to focus on impact of contamination on the p...
April 30, 2023 | News
The MALETH Project, which was led by Professor Joseph Borg from the University of Malta brought internationally excelling scientists to...
April 30, 2023 | Company results
ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 ...
April 28, 2023 | News
Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...
April 27, 2023 | News
Most Read
Bio Jobs
News